Back

Predictors of mitral valve hemodynamics after mitral valve repair for degenerative mitral regurgitation: a subanalysis of the CAMRA randomized trial

26 August 2022 (08:00 - 19:30)
Organised by:
Congress Presentation Part of: Mitral valve interventions / TEER Mitral Valve Intervention ESC Professional Premium Access ESC Congress 2022

About the speaker

Photo
Doctor Rawan Rumman

St. Michael's Hospital, Toronto (Canada)

6 More presentations in this session

Presentation thumbnail
Validation of expert criteria proposed by the "German Cardiac Society" for predicting procedural complexity in transcatheter edge-to-edge mitral valve repair
Doctor C. Metze (Cologne, DE)
Abstract Slides
Presentation thumbnail
Staging heart failure patients with secondary mitral regurgitation undergoing transcatheter edge-to-edge repair
Mr L. Stolz (Munich, DE)
Abstract Slides
Presentation thumbnail
5-year outcomes of patients with mitral structural valve deterioration treated with transcatheter valve in valve implantation
Doctor N. Schamroth Pravda (Petah Tikva, IL)
Abstract Slides
Presentation thumbnail
Transcatheter mitral-valve repair for functional mitral regurgitation data from the real-life in comparison with landmark randomized trials
Doctor R. Kaddoura (Doha, QA)
Abstract Slides
Presentation thumbnail
Effect of frailty on in-hospital outcomes after transcatheter mitral valve repair
Doctor J. Lopez (Aventura, US)
Abstract Slides

Access the full session

Session thumbnail
Mitral valve interventions / TEER

The Event

Event poster

ESC Congress 2022

26 August - 29 August 2022
You may be interested in
thumbnail
Congress Session
2025 ESC/EACTS Guidelines for the Management of Valvular Heart Disease
thumbnail
Congress Presentation
Tea-for-two in the cath lab: image guidance transcatheter mitral valve replacement
thumbnail
Congress Session
Failing valves and beyond

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources